Drugs.com Newsletter Archive

Our popular newsletter containing a regular roundup of medication news, alerts and new drug approvals.

Archive

Monthly News Roundup Vol 179, July 2019
Monthly News Roundup Vol 178, June 2019
Monthly News Roundup Vol 177, May 2019
Monthly News Roundup Vol 176, April 2019
Monthly News Roundup Vol 175, March 2019
Monthly News Roundup Vol 174, February 2019
Monthly News Roundup Vol 173, January 2019
Monthly News Roundup Vol 172, December 2018
Monthly News Roundup Vol 171, November 2018
Monthly News Roundup Vol 170, October 2018
Monthly News Roundup Vol 169, September 2018

Recently Approved

Xenleta
Xenleta (lefamulin) is a first-in-class, semi-synthetic pleuromutilin...
Rinvoq
Rinvoq (upadacitinib) is a Janus kinase (JAK) inhibitor for the treatment of...
Inrebic
Inrebic (fedratinib) is a highly selective JAK2 inhibitor for the treatment of...
Rozlytrek
Rozlytrek (entrectinib) is a selective tyrosine kinase inhibitor for the...

Subscribe to our newsletters

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include IBM Watson Micromedex (updated 1 Aug 2019), Cerner Multum™ (updated 1 Aug 2019), Wolters Kluwer™ (updated 31 July 2019) and others.

Drugs.com Newsletter Archive

Archive

Support

About

Terms & Privacy

Drugs.com Newsletter Archive

Archive

Drugs.com Mobile Apps

Support

About

Terms & Privacy